Amgen, Inc. (AMGN)
NGS · Common · CUSIP 031162100
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for AMGN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
031162100
Market Cap
Large Cap · $121 Billion
Business: Amgen Inc. discovers, develops, manufactures, and delivers innovative human therapeutics. A leader in biotechnology since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe, effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses.

Company Contact

CEO
Robert A. Bradway
CFO
Peter Griffith
Headquarters
One Amgen Center Drive, Thousand Oaks, CA 91320
Phone
805-447-1000
Fax
805-499-0792
Investor Relations
Arvind Sood · 805-447-1060 · investor.relations@amgen.com
Email Form
Request Form »
SEC EDGAR Filings
View filings »
Find all related securities for AMGN »